1/19/2023 – Avivagen Announces Foundational Scientific and Commercial Evidence of OxC-Beta(TM) Product Published in Peer-Reviewed Journal
10/31/2022 – Avivagen Inc. Announces Closing of Second Tranche of a Private Placement of Shares
© 2023 Streetwise Reports. All rights reserved.
Streetwise Reports is registered with the U.S. Patent and Trademark Office.